stem cell therapy for diabetes(Johnson & Johnson)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namestem cell therapy for diabetes(Johnson & Johnson)
Drug Alias Namestem cell therapy for diabetes(ViaCyte)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Pancreatic stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesViacyte IncJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A